• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体靶向多功能纳米颗粒结合铜死亡和程序性细胞死亡-1 下调用于癌症免疫治疗。

Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer Immunotherapy.

机构信息

Department of Chemistry, University of Chicago, 929 East 57th Street, Chicago, IL, 60637, USA.

Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, University of Chicago, 5758 South Maryland Avenue, Chicago, IL, 60637, USA.

出版信息

Adv Sci (Weinh). 2024 Sep;11(35):e2403520. doi: 10.1002/advs.202403520. Epub 2024 Jul 16.

DOI:10.1002/advs.202403520
PMID:39013093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11425249/
Abstract

The combination of cuproptosis and immune checkpoint inhibition has shown promise in treating malignant tumors. However, it remains a challenge to deliver copper ions and immune checkpoint inhibitors efficiently and simultaneously to tumors. Herein, a mitochondria-targeted nanoscale coordination polymer particle, Cu/TI, comprising Cu(II), and a triphenylphosphonium conjugate of 5-carboxy-8-hydroxyquinoline (TI), for effective cuproptosis induction and programmed cell death-1 (PD-L1) downregulation is reported. Upon systemic administration, Cu/TI efficiently accumulates in tumor tissues to induce immunogenic cancer cell death and reduce PD-L1 expression. Consequently, Cu/TI promotes the intratumoral infiltration and activation of cytotoxic T lymphocytes to greatly inhibit tumor progression of colorectal carcinoma and triple-negative breast cancer in mouse models without causing obvious side effects.

摘要

铜死亡与免疫检查点抑制的联合治疗在恶性肿瘤的治疗中显示出了潜力。然而,高效且同时将铜离子和免疫检查点抑制剂递送到肿瘤部位仍然是一个挑战。在此,报道了一种线粒体靶向纳米级配位聚合物粒子 Cu/TI,它由 Cu(II)和 5-羧基-8-羟基喹啉的三苯基膦缀合物(TI)组成,可有效诱导铜死亡和程序性细胞死亡配体 1(PD-L1)下调。在系统给药后,Cu/TI 能够有效地在肿瘤组织中积累,从而诱导免疫原性细胞死亡并降低 PD-L1 的表达。因此,Cu/TI 促进了肿瘤内细胞毒性 T 淋巴细胞的浸润和激活,从而极大地抑制了结直肠癌和三阴性乳腺癌在小鼠模型中的肿瘤进展,且没有引起明显的副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/1f94a8be957e/ADVS-11-2403520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/ab700eb6d21d/ADVS-11-2403520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/fda3747707c3/ADVS-11-2403520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/cc84b3d1b6a3/ADVS-11-2403520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/48abd104954f/ADVS-11-2403520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/3d1e0ba7b1c8/ADVS-11-2403520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/b604ad3edb34/ADVS-11-2403520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/1f94a8be957e/ADVS-11-2403520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/ab700eb6d21d/ADVS-11-2403520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/fda3747707c3/ADVS-11-2403520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/cc84b3d1b6a3/ADVS-11-2403520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/48abd104954f/ADVS-11-2403520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/3d1e0ba7b1c8/ADVS-11-2403520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/b604ad3edb34/ADVS-11-2403520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e4/11425249/1f94a8be957e/ADVS-11-2403520-g004.jpg

相似文献

1
Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer Immunotherapy.线粒体靶向多功能纳米颗粒结合铜死亡和程序性细胞死亡-1 下调用于癌症免疫治疗。
Adv Sci (Weinh). 2024 Sep;11(35):e2403520. doi: 10.1002/advs.202403520. Epub 2024 Jul 16.
2
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.靶向磷脂酰丝氨酸的抗体通过增强免疫激活和下调小鼠三阴性乳腺癌中由T细胞检查点抑制诱导的促癌因子,增强抗PD-1疗法的抗肿瘤活性。
Breast Cancer Res. 2016 May 11;18(1):50. doi: 10.1186/s13058-016-0708-2.
3
Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.多肽疫苗偶联介孔载体与免疫原性细胞死亡和 PD-L1 阻断协同作用,增强转移性脊柱肿瘤的免疫治疗。
J Nanobiotechnology. 2021 Aug 12;19(1):243. doi: 10.1186/s12951-021-00975-5.
4
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy.纳米颗粒协同铁死亡和铜死亡增强癌症免疫治疗。
Adv Sci (Weinh). 2024 Jun;11(23):e2310309. doi: 10.1002/advs.202310309. Epub 2024 Mar 13.
5
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.组蛋白赖氨酸特异性去甲基酶 1 的抑制可引发乳腺癌肿瘤免疫,并增强免疫检查点阻断的抗肿瘤疗效。
Oncogene. 2019 Jan;38(3):390-405. doi: 10.1038/s41388-018-0451-5. Epub 2018 Aug 15.
6
Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.基于生物纳米颗粒的疫苗和检查点阻断刺激的适应性抗肿瘤免疫反应。
J Exp Clin Cancer Res. 2022 Apr 8;41(1):132. doi: 10.1186/s13046-022-02307-3.
7
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.局部和靶向递送免疫检查点阻断治疗药物。
Acc Chem Res. 2020 Nov 17;53(11):2521-2533. doi: 10.1021/acs.accounts.0c00339. Epub 2020 Oct 19.
8
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.纳米胶束保护紫杉醇的免疫激活作用,并使肿瘤对抗 PD-1 免疫治疗敏感。
Theranostics. 2020 Jul 9;10(18):8382-8399. doi: 10.7150/thno.45391. eCollection 2020.
9
BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response.BET 蛋白靶向抑制三阴性乳腺癌中的 PD-1/PD-L1 通路并引发抗肿瘤免疫反应。
Cancer Lett. 2019 Nov 28;465:45-58. doi: 10.1016/j.canlet.2019.08.013. Epub 2019 Aug 29.
10
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.RAS/MAPK激活与三阴性乳腺癌中肿瘤浸润淋巴细胞减少相关:MEK与PD-1/PD-L1免疫检查点抑制剂之间的治疗协同作用
Clin Cancer Res. 2016 Mar 15;22(6):1499-509. doi: 10.1158/1078-0432.CCR-15-1125. Epub 2015 Oct 29.

引用本文的文献

1
A mitochondria targeted nitroreductase-sensitive self-immolative spacer as an efficient shuttle for uncharged amine-based molecules.一种靶向线粒体的对硝基还原酶敏感的自裂解间隔基,作为不带电荷的胺基分子的有效载体。
Chem Sci. 2025 Jul 16. doi: 10.1039/d5sc03665h.
2
Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.治疗性癌症疫苗靶向递送载体的战略进展
Int J Mol Sci. 2025 Jul 17;26(14):6879. doi: 10.3390/ijms26146879.
3
Mechanism and application of copper-based nanomedicines in activating tumor immunity through oxidative stress modulation.

本文引用的文献

1
A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.一种自扩增的 ROS 响应型纳米平台,用于同时实现铜死亡和癌症免疫治疗。
Adv Sci (Weinh). 2024 Jun;11(23):e2401047. doi: 10.1002/advs.202401047. Epub 2024 Apr 3.
2
Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes.通过纳米颗粒诱导的胞质钙变化调节树突状细胞功能
ACS Nano. 2024 Mar 12;18(10):7618-7632. doi: 10.1021/acsnano.4c00550. Epub 2024 Feb 29.
3
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
铜基纳米药物通过氧化应激调节激活肿瘤免疫的机制与应用
Front Pharmacol. 2025 Jul 11;16:1646890. doi: 10.3389/fphar.2025.1646890. eCollection 2025.
4
Novel Pt@PCN-Cu-induced cuproptosis amplifies αPD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation.新型铂@多孔共价有机网络-铜诱导的铜死亡通过线粒体己糖激酶2介导的程序性死亡配体1上调增强胰腺导管腺癌中的α程序性死亡配体1免疫疗法。
J Exp Clin Cancer Res. 2025 May 17;44(1):149. doi: 10.1186/s13046-025-03409-4.
5
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer.癌症中铜及铜死亡的分子机制与治疗前景
Signal Transduct Target Ther. 2025 May 9;10(1):149. doi: 10.1038/s41392-025-02192-0.
6
Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis.对抗癌症耐药性的策略:聚焦铜代谢与铜死亡
Cancer Drug Resist. 2025 Mar 26;8:15. doi: 10.20517/cdr.2025.41. eCollection 2025.
7
Mitochondria-Targeted Biomaterials-Regulating Macrophage Polarization Opens New Perspectives for Disease Treatment.线粒体靶向生物材料调节巨噬细胞极化开启疾病治疗新视角。
Int J Nanomedicine. 2025 Feb 4;20:1509-1528. doi: 10.2147/IJN.S505591. eCollection 2025.
8
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy.结直肠癌微环境中的铜:开创基于铜死亡疗法的新时代。
Front Oncol. 2025 Jan 9;14:1522919. doi: 10.3389/fonc.2024.1522919. eCollection 2024.
9
Biometallic ions and derivatives: a new direction for cancer immunotherapy.生物金属离子及其衍生物:癌症免疫治疗的新方向。
Mol Cancer. 2025 Jan 15;24(1):17. doi: 10.1186/s12943-025-02225-w.
多模态神经纳米技术:挑战胶质母细胞瘤治疗的现有范式。
Proc Natl Acad Sci U S A. 2024 Feb 20;121(8):e2306973121. doi: 10.1073/pnas.2306973121. Epub 2024 Feb 12.
4
Self-Disassembling and Oxygen-Generating Porphyrin-Lipoprotein Nanoparticle for Targeted Glioblastoma Resection and Enhanced Photodynamic Therapy.用于靶向脑胶质瘤切除和增强光动力治疗的自组装产氧卟啉脂蛋白纳米颗粒。
Adv Mater. 2024 Apr;36(15):e2307454. doi: 10.1002/adma.202307454. Epub 2024 Feb 7.
5
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy.免疫原性双功能纳米颗粒抑制癌症和树突状细胞中的程序性细胞死亡配体1,以增强适应性免疫和化学免疫疗法。
ACS Nano. 2024 Feb 13;18(6):5152-5166. doi: 10.1021/acsnano.3c12678. Epub 2024 Jan 29.
6
Stimulus-Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy.刺激响应型铜配合物纳米颗粒诱导铜死亡增强癌症免疫治疗。
Adv Sci (Weinh). 2024 Apr;11(13):e2309388. doi: 10.1002/advs.202309388. Epub 2024 Jan 25.
7
Nanoscale Covalent Organic Framework with Staggered Stacking of Phthalocyanines for Mitochondria-Targeted Photodynamic Therapy.具有酞菁交错堆叠结构的纳米级共价有机框架用于线粒体靶向光动力治疗
J Am Chem Soc. 2024 Jan 10;146(1):849-857. doi: 10.1021/jacs.3c11092. Epub 2023 Dec 22.
8
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.铜死亡:克服癌症药物耐药性的新治疗靶点。
Drug Resist Updat. 2024 Jan;72:101018. doi: 10.1016/j.drup.2023.101018. Epub 2023 Nov 11.
9
Laser-Activatable In Situ Vaccine Enhances Cancer-Immunity Cycle.激光激活型原位疫苗增强癌症免疫循环。
Adv Mater. 2023 Dec;35(52):e2307193. doi: 10.1002/adma.202307193. Epub 2023 Nov 21.
10
Nanomaterial-Enabled Photothermal Heating and Its Use for Cancer Therapy via Localized Hyperthermia.纳米材料促进的光热加热及其在局部热疗治疗癌症中的应用。
Small. 2024 Feb;20(7):e2305426. doi: 10.1002/smll.202305426. Epub 2023 Oct 6.